Cancer Summaries and Commentaries : Update from Chicago : Advances in the Treatment of Genitourinary Cancers
WebcastFaculty
OVERVIEW
Cancer Summaries and Commentaries : Update from Chicago : Advances in the Treatment of Genitourinary Cancers is organized by Physicians Education Resource, LLC (PER) and would be held during Jul 28, 2016 - Jul 28, 2017.
The target audience for this medical event for surgical, and radiation oncologists involved in the treatment of patients with GU malignancies. Urologists, fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, nuclear medicine physicians, and other healthcare professionals interested in the treatment of GU malignancies may also participate. This CME Conference has been approved with a maximum of 1.5 AMA PRA Category 1 Credits.
Conference Objectives are :
• Explain recent results of clinical trials conducted in patients with GU cancers.
• Discuss emerging evidence in the context of evolving treatment paradigms in clinical settings where patients with GU cancers receive care.
• Evaluate the benefit of clinical trial participation for improving outcomes among patients with GU cancers and limited treatment options.
Additional details will be posted as soon as they are available.
The target audience for this medical event for surgical, and radiation oncologists involved in the treatment of patients with GU malignancies. Urologists, fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, nuclear medicine physicians, and other healthcare professionals interested in the treatment of GU malignancies may also participate. This CME Conference has been approved with a maximum of 1.5 AMA PRA Category 1 Credits.
Conference Objectives are :
• Explain recent results of clinical trials conducted in patients with GU cancers.
• Discuss emerging evidence in the context of evolving treatment paradigms in clinical settings where patients with GU cancers receive care.
• Evaluate the benefit of clinical trial participation for improving outcomes among patients with GU cancers and limited treatment options.
Additional details will be posted as soon as they are available.
SPECIALITIES
Oncology
Quick Links